Received Feb 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
received his first Shingrix dose in his doctor's office over 2 years ago; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 55-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received first dose over 2 years ago). On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: received his first Shingrix dose in his doctor's office over 2 years ago). The outcome of the incomplete course of vaccination was unknown. Additional Information: GSK Receipt Date: 06-FEB-2025 The pharmacist reported that a patient had received his first Shingrix dose in his doctor office might had been before covid and wants to know that the patient still get the second dose or he start over. Till the time of reporting, the patient did not receive second dose of Shingrix which led to incomplete course of vaccination. This was 1 of the 4 cases, reported by the same reporter.; Sender's Comments: US-GLAXOSMITHKLINE-US2020239730:same reporter US-GSK-US2020209374:same reporter US-GSK-US2020209373:same reporter